Dipeptidyl peptidase-4 (DPP-IV) inhibitor was associated with mortality reduction in COVID-19 — A systematic review and meta-analysis

INTRODUCTION: This systematic review and meta-analysis aimed to synthesize the latest evidence on the effect of dipeptidyl peptidase-4 (DPP-IV) inhibitor in patients with COVID-19. METHODS: We performed a systematic literature search from the PubMed, Scopus, Embase, and Clinicaltrials.gov up until 1...

Descripción completa

Detalles Bibliográficos
Autores principales: Zein, Ahmad Fariz Malvi Zamzam, Raffaello, Wilson Matthew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd on behalf of Primary Care Diabetes Europe. 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666291/
https://www.ncbi.nlm.nih.gov/pubmed/34952805
http://dx.doi.org/10.1016/j.pcd.2021.12.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666291/
https://www.ncbi.nlm.nih.gov/pubmed/34952805
http://dx.doi.org/10.1016/j.pcd.2021.12.008

Ejemplares similares